A prospective, real-world, clinical pharmacokinetic study to inform lacosamide dosing in critically ill patients undergoing continuous venovenous haemofiltration (PADRE-02).

Kalaria, Shamir N; Armahizer, Michael; McCarthy, Paul; Badjatia, Neeraj; Gobburu, Jogarao V; Gopalakrishnan, Mathangi

Kalaria, Shamir N; Armahizer, Michael; McCarthy, Paul; Badjatia, Neeraj; Gobburu, Jogarao V; Gopalakrishnan, Mathangi.

Afiliação

Kalaria SN; Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, United States.
Armahizer M; Department of Pharmacy Services, University of Maryland Medical Center, Baltimore, Maryland, United States.
McCarthy P; Department of Pharmacy Services, University of Maryland Medical Center, Baltimore, Maryland, United States.
Badjatia N; Department of Cardiovascular and Thoracic Surgery, Division of Critical Care, West Virginia University School of Medicine, Morgantown, West Virginia, United States.
Gobburu JV; Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland, United States.
Gopalakrishnan M; Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, United States.

Br J Clin Pharmacol ; 87(11): 4375-4385, 2021 11.

Article em En | MEDLINE | ID: mdl-33855736

Assuntos

Terapia de Substituição Renal Contínua; Hemofiltração; Antibacterianos; Estado Terminal/terapia; Humanos; Lacosamida; Estudos Prospectivos; Raios Ultravioleta

Palavras-chave

critical care; dialysis; epilepsy; pharmacokinetics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemofiltração / Terapia de Substituição Renal Contínua Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google